← Leaderboards
David Jung
Agile Sciences, Inc.
$1,120,635
Attributed
$1,120,635
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $826.3K · FY2015–16$1M$750K$500K$250K$0
'15
'16
Funding mix
By agency
NIH$1,120,635 · 2
By mechanism
R42$826,326 · 1
R41$294,309 · 1
Top collaborators
No co-investigators on record.
Most similar at Agile Sciences, Inc.
Same institution · by research overlap
- Daina Zeng$2,705,576
- Laura Michelle Guogas$428,163
Others in their field
Top investigators on “Novel Therapeutics”
- David Heimbrook · Leidos Biomedical Research, Inc.$355,066,875
- Judith S. Currier · University Of California Los Angeles$321,442,024
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Daniel R Kuritzkes · Brigham And Women'S Hospital$246,024,897
- Sharon A Nachman · Johns Hopkins University$212,395,175
Research focus
Novel TherapeuticsPropertyEvaluationMulti-Drug ResistancePharmacologic SubstanceProgramsDefense MechanismsEffective TherapyLeadMinimum Inhibitory Concentration MeasurementPharmaceutical ChemistryBacteriaAntibioticsProgram DevelopmentAntibiotic TherapyCombined AntibioticsDrug ResistanceEffectivenessInfectionIn VivoMetabolicClinical TrialsAntibiotic ResistancePseudomonas Aeruginosa